0.82
-0.0419(-4.84%)
Currency In USD
| Previous Close | 0.87 |
| Open | 0.86 |
| Day High | 0.87 |
| Day Low | 0.81 |
| 52-Week High | 3.09 |
| 52-Week Low | 0.66 |
| Volume | 115,934 |
| Average Volume | 173,095 |
| Market Cap | 103.95M |
| PE | -1.53 |
| EPS | -0.54 |
| Moving Average 50 Days | 0.85 |
| Moving Average 200 Days | 1.9 |
| Change | -0.04 |
If you invested $1000 in Nautilus Biotechnology, Inc. (NAUT) since IPO date, it would be worth $78.93 as of May 18, 2025 at a share price of $0.824. Whereas If you bought $1000 worth of Nautilus Biotechnology, Inc. (NAUT) shares 3 years ago, it would be worth $211.28 as of May 18, 2025 at a share price of $0.824.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025
GlobeNewswire Inc.
Apr 16, 2025 12:00 PM GMT
SEATTLE, April 16, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today announced it will report financial results for the first quarter 2025 b
Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference
GlobeNewswire Inc.
Feb 18, 2025 1:00 PM GMT
SEATTLE, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be participating
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
GlobeNewswire Inc.
Feb 06, 2025 1:00 PM GMT
SEATTLE, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule protein analysis platform, today announced it will report financial results for the fourth quarter and ful